Showing results (331-340 of 365) with videos related to

Sort By:
Pageof 37
European Urology|August 25, 2019
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 UpdateMarko Babjuk, Maximilian Burger, Eva M Compérat, et al.
European Urology|September 13, 2021
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)Marko Babjuk, Maximilian Burger, Otakar Capoun, et al.
European Urology|June 29, 2020
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 UpdateMorgan Rouprêt, Marko Babjuk, Maximilian Burger, et al.
Diagnostic Microbiology and Infectious Disease|August 2, 2022
Cepheid Xpert Xpress Flu/RSV evaluation performed by minimally trained non-laboratory operators in a CLIA-waived environmentBashar S Shihabuddin, Matthew L Faron, Ryan F Relich, et al.
Elife|November 29, 2021
Remote immune processes revealed by immune-derived circulating cell-free DNAIlana Fox-Fisher, Sheina Piyanzin, Bracha Lea Ochana, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 4, 2023
The discovery and evaluation of [18F]BMS-986229, a novel macrocyclic peptide PET radioligand for the measurement of PD-L1 expression and in-vivo PD-L1 target engagementDavid J Donnelly, Joonyoung Kim, Tritin Tran, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 14, 2017
Synthesis and Biologic Evaluation of a Novel 18F-Labeled Adnectin as a PET Radioligand for Imaging PD-L1 ExpressionDavid J Donnelly, R Adam Smith, Paul Morin, et al.
Vaccines|February 26, 2022
Neutralization of SARS-CoV-2 Variants by rVSV-ΔG-Spike-Elicited Human SeraYfat Yahalom-Ronen, Noam Erez, Morly Fisher, et al.
Pageof 37